Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic ...

Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced it has received U.S. Food and Drug Administration (FDA ...

BECKLEY, WV (WVNS) — Dr. Lynetta Payne, a urologist at Raleigh General Hospital, has reached the milestone of 200 successful ...

I’m 79, and for several years, I have been taking finasteride and tamsulosin for benign prostatic hyperplasia. (In the past, I underwent a TURP procedure, which I will never go through again.) As we ...

In addition to new medications to treat this enzyme deficiency, research is underway on easier hormone sampling and fixing the gene mutation that causes CAH.

Neurocrine Biosciences has rebounded 60% since April 2025, driven by robust Ingrezza sales and Crenessity's uncontested launch. Read why NBIX stock is a hold.

GUANGZHOU CITY, GUANGDONG PROVINCE, CHINA, March 17, 2026 /EINPresswire.com/ — The global market for non-invasive body contouring has expanded steadily over the past several years, and cryolipolysis ...

The Brookbush Institute continues to enhance education with new articles, new courses, a modern glossary, an AI Tutor, ...

Learn how to manage congenital adrenal hyperplasia during illness, including sick day rules for stress dosing, using injectables, and preventing adrenal crisis.

A massive meta-analysis of over 227,000 people reveals that finger length ratios — shaped by prenatal hormones — correlate ...

The last couple of decades has seen increased attention by scientists and medical researchers on drug repurposing and the potential of fenbendazole. Fenbendazole has traditionally been used as an ...